approval
saveBRIXADI (BUPRENORPHINE) — FDA approval
community read0 votes
Sponsor: BRAEBURN. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalDec 22, 2025 · 294d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalDec 22, 2025 · 294d ago
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalAug 29, 2025 · 409d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalApr 11, 2025 · 549d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalFeb 21, 2025 · 598d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalApr 19, 2024 · 906d ago
- approvalSUBLOCADE (BUPRENORPHINE) — FDA approvalDec 15, 2023 · 1032d ago
- approvalBRIXADI (BUPRENORPHINE) — FDA approvalDec 15, 2023 · 1032d ago
comments(0)
5-min edit window · permanent after that